Ads
related to: home remedy for venous insufficiency in lower
Search results
Results From The WOW.Com Content Network
Chronic venous insufficiency (CVI) is a medical condition characterized by blood pooling in the veins, leading to increased pressure and strain on the vein walls. [1] The most common cause of CVI is superficial venous reflux, which often results in the formation of varicose veins , a treatable condition. [ 2 ]
Its seeds, leaves, bark, and flowers have been used medicinally for many centuries for treating joint pain, bladder and gastrointestinal problems, fever, leg cramps, and other conditions. It may be useful for treating chronic venous insufficiency. The raw plant materials are toxic unless processed. [7] Ageratina altissima: White snakeroot
Pelvic congestion syndrome, Pelvic venous insufficiency, Pelvic varicocele syndrome: A very large (9 cm) fibroid of the uterus which is causing pelvic congestion syndrome as seen on X-ray computed tomography: Specialty: Interventional Radiology, gynecology: Symptoms: Chronic pelvic pain, lower back pain, leg pain, dyspareunia, dysmenorrhea [1 ...
For venous insufficiency, the dosage is 2 tablets of 500mg daily. For acute hemorrhoidal attack, the dosage is 6 tablets daily for 4 days, followed by 4 tablets daily over the next 3 days. [15] For chronic venous disease, the dosage is 2 tablets a day for at least 2 months. [16]
Venous insufficiency is the most common disorder of the venous system, and is usually manifested as either spider veins or varicose veins. Several treatments are available including endovenous thermal ablation (using radiofrequency or laser energy), vein stripping, ambulatory phlebectomy, foam sclerotherapy, laser, or compression. [citation needed]
Diosmin is a dietary supplement used to aid treatment of hemorrhoids and venous diseases, i.e., chronic venous insufficiency including spider and varicose veins, leg swelling , stasis dermatitis and venous ulcers. [1] The mechanism of action of Diosmin and other phlebotonics is undefined, [1] and clinical evidence of benefit is limited. [1]